Skandinaviska Enskilda Banken (SEB)
XENE icon

Skandinaviska Enskilda Banken (SEB)’s Xenon Pharmaceuticals XENE Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,457
Closed -$1.49M – 897
2025
Q2 		$1.49M Hold
47,457
– – 0.01% 615
2025
Q1 		$1.59M Buy
47,457
+7,081
+18% +$269K 0.01% 599
2024
Q4 		$1.56M Hold
40,376
– – 0.01% 610
2024
Q3 		$1.59M Hold
40,376
– – 0.01% 623
2024
Q2 		$1.57M Buy
+40,376
New +$1.61M 0.01% 595

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s XENE Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Xenon Pharmaceuticals (XENE) in Q3 2025, closing a stake of 47,457 shares — an estimated $1.49M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in XENE in Q2 2024 and held it in 5 quarters. The position peaked at $1.59M in Q1 2025. 219 funds tracked by Wall St. Rank hold XENE as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Xenon Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 47,457 Xenon Pharmaceuticals shares in Q3 2025, an estimated $1.49M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Xenon Pharmaceuticals in Q2 2024 and held it in 5 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Xenon Pharmaceuticals position peaked at $1.59M in Q1 2025.
  • 219 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.